Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
Hydralazine is a commonly used anti-hypertensive medication. It can, however, contribute to the development of autoimmunity, in the form of drug-induced lupus and anti-neutrophil cytoplasmic antibodies-associated vasculitis. We report a 45-year-old patient with hypertension managed with hydralazine...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| סדרה: | Saudi Journal of Kidney Diseases and Transplantation |
| גישה מקוונת: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=1;spage=226;epage=230;aulast=Paley |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|